Small molecules behaving as CD4 mimics were previously reported as HIV-1 entry inhibitors that block the gp120–CD4 interaction and induce a conformational change in gp120, exposing its co-receptor-binding site. A structure–activity relationship (SAR) study of a series of CD4 mimic analogs was conducted to investigate the contribution from the piperidine moiety of CD4 mimic 1 to anti-HIV activity, cytotoxicity, and CD4 mimicry effects on ...
[Sengupta, Saumitra; Rao, G. Venkateshwar; Dubey Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2011 , vol. 50, # 7 p. 901 - 905]